Systemic Embolism
7
2
3
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination
Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial
The Fourth Left Atrial Appendage Occlusion Study
NOAC Portuguese Real World Study
Efficacy and Safety of Edoxaban in Patients With Atrial Fibrillation and Mitral Stenosis
Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation
LAA Excision With AF Ablation Versus Oral Anticoagulants for Secondary Prevention of Stroke